Moving forward, we plan to couple this model with other mechanistic models that simulate the effects of RA therapy on the expression levels of TF, CP, PAI-1, PAI-2, t-PA and u-PA, and compare the significance of different pathways in RA therapy of clotting disorders in cancer patients. This evidence concerns the gene TF and cancer.